Treatment of Radiation-induced Cognitive Decline

Overview

Journal Curr Treat Options Oncol

Specialty Oncology

Date 2014 Sep 18

PMID 25228143

Citations 27

Authors

Albert Attia

Brandi R Page

Glenn J Lesser

Michael Chan

Affiliations

Soon will be listed here.

Abstract

Radiation-induced cognitive decline in cancer survivors who have received brain radiotherapy is an insidious problem with worsening severity over time. Because of improved survival with modern therapies, an increasing number of long term survivors are affected with limited options for treatment once diagnosed. Recently there has been enthusiasm for evaluating new approaches to prevent the onset of radiation-induced cognitive decline. Clinical trials have assessed the role of pharmaceuticals such as memantine and donepezil in ameliorating the cognitive effects of brain irradiation. Radiosurgery, when clinically appropriate, allows for the avoidance or postponement of whole brain radiotherapy in some patients with brain metastases. Hippocampal-sparing intensity modulated radiotherapy has been proposed as a means of avoiding damage to regions of adult neurogenesis. Finally, cytoprotective agents are being investigated that target the molecular pathways that lead to brain injury and the resultant cognitive decline.

Citing Articles

Investigation of high-dose radiotherapy's effect on brain structure aggravated cognitive impairment and deteriorated patient psychological status in brain tumor treatment.

Ma J, Cao H, Hou D, Wang W, Liu T Sci Rep. 2024; 14(1):10149.

PMID: 38698048 PMC: 11066031. DOI: 10.1038/s41598-024-59694-0.

Functional Approaches to the Surgery of Brain Gliomas.

Giampiccolo D, Nunes S, Cattaneo L, Sala F Adv Tech Stand Neurosurg. 2022; 45:35-96.

PMID: 35976447 DOI: 10.1007/978-3-030-99166-1_2.

The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes.

Major N, Patel N, Bennett J, Novakovic E, Poloni D, Abraham M J Pers Med. 2022; 12(7).

PMID: 35887547 PMC: 9315742. DOI: 10.3390/jpm12071050.

Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative Review.

Scampoli C, Cammelli S, Galietta E, Siepe G, Buwenge M, Macchia G Cancers (Basel). 2022; 14(11).

PMID: 35681716 PMC: 9179311. DOI: 10.3390/cancers14112736.

Radiation dose to circumscribed brain regions and neurocognitive function in patients with meningioma.

Sekely A, Tsang D, Mabbott D, Kongkham P, Zadeh G, Zakzanis K Neurooncol Pract. 2022; 9(3):208-218.

PMID: 35601975 PMC: 9113401. DOI: 10.1093/nop/npac011.

References

Peiffer A, Leyrer C, Greene-Schloesser D, Shing E, Kearns W, Hinson W . Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013; 80(8):747-53. PMC: 3589296. DOI: 10.1212/WNL.0b013e318283bb0a. View

Ayala-Peacock D, Peiffer A, Lucas J, Isom S, Kuremsky J, Urbanic J . A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014; 16(9):1283-8. PMC: 4136890. DOI: 10.1093/neuonc/nou018. View

Brown P, Pugh S, Laack N, Wefel J, Khuntia D, Meyers C . Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013; 15(10):1429-37. PMC: 3779047. DOI: 10.1093/neuonc/not114. View

Matthews D, Charbonnel B, Hanefeld M, Brunetti P, Schernthaner G . Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev. 2004; 21(2):167-74. DOI: 10.1002/dmrr.478. View

Danysz W, Parsons C, Schwaier A, Popik P, Wedzony K, Lazarewicz J . GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids. 1999; 14(1-3):235-9. DOI: 10.1007/BF01345268. View

Lee P, Hung B, Woo E, Tai P, Choi D . Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry. 1989; 52(4):488-92. PMC: 1032297. DOI: 10.1136/jnnp.52.4.488. View

MacDonald S, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap B . Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008; 71(4):979-86. DOI: 10.1016/j.ijrobp.2007.11.065. View

Zhao W, Payne V, Tommasi E, Diz D, Hsu F, Robbins M . Administration of the peroxisomal proliferator-activated receptor gamma agonist pioglitazone during fractionated brain irradiation prevents radiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys. 2006; 67(1):6-9. DOI: 10.1016/j.ijrobp.2006.09.036. View

Raber J, Rola R, LeFevour A, Morhardt D, Curley J, Mizumatsu S . Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res. 2004; 162(1):39-47. DOI: 10.1667/rr3206. View

10.

Delong R, Friedman H, Friedman N, Gustafson K, Oakes J . Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol. 1992; 7(4):462-3. DOI: 10.1177/088307389200700425. View

11.

DeAngelis L, Seiferheld W, Clifford Schold S, Fisher B, Schultz C . Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 2002; 20(24):4643-8. DOI: 10.1200/JCO.2002.11.013. View

12.

Attia A, Rapp S, Case L, DAgostino R, Lesser G, Naughton M . Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. J Neurooncol. 2012; 109(2):357-63. PMC: 3752650. DOI: 10.1007/s11060-012-0901-9. View

13.

Auperin A, Arriagada R, Pignon J, Le Pechoux C, Gregor A, Stephens R . Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999; 341(7):476-84. DOI: 10.1056/NEJM199908123410703. View

14.

Butler Jr J, Case L, Atkins J, Frizzell B, Sanders G, Griffin P . A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007; 69(5):1496-501. DOI: 10.1016/j.ijrobp.2007.05.076. View

15.

Cheung M, Chan A, Law S, Chan J, Tse V . Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol. 2000; 57(9):1347-52. DOI: 10.1001/archneur.57.9.1347. View

16.

Chang E, Wefel J, Hess K, Allen P, Lang F, Kornguth D . Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009; 10(11):1037-44. DOI: 10.1016/S1470-2045(09)70263-3. View

17.

Jenrow K, Brown S, Liu J, Kolozsvary A, Lapanowski K, Kim J . Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus. Radiat Oncol. 2010; 5:6. PMC: 2825515. DOI: 10.1186/1748-717X-5-6. View

18.

Page B, Shaw E, Lu L, Bryant D, Grisell D, Lesser G . Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015; 17(10):1393-401. PMC: 4578583. DOI: 10.1093/neuonc/nov084. View

19.

Tofilon P, Fike J . The radioresponse of the central nervous system: a dynamic process. Radiat Res. 2000; 153(4):357-70. DOI: 10.1667/0033-7587(2000)153[0357:trotcn]2.0.co;2. View

20.

Torres I, Mundt A, Sweeney P, Llanes-Macy S, Dunaway L, Castillo M . A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology. 2003; 60(7):1113-8. DOI: 10.1212/01.wnl.0000055862.20003.4a. View